dihydrotestosterone has been researched along with Polycystic Ovarian Syndrome in 139 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (16.55) | 18.7374 |
| 1990's | 5 (3.60) | 18.2507 |
| 2000's | 13 (9.35) | 29.6817 |
| 2010's | 62 (44.60) | 24.3611 |
| 2020's | 36 (25.90) | 2.80 |
| Authors | Studies |
|---|---|
| Billig, H; Brännström, M; Hu, M; Li, J; Liang, M; Ma, H; Ma, S; Sferruzzi-Perri, AN; Shao, LR; Wang, X; Wu, X; Zhang, Y | 1 |
| Cui, P; Feng, Y; Hu, W; Li, X; Liu, Y; Lu, W; Ma, T; Pei, Z; Shi, J; Tong, X; Xu, C; Xu, M; Xu, X; Zhang, F | 1 |
| Campbell, RE; Coyle, CS; Handelsman, DJ; Prescott, M; Walters, KA | 1 |
| Mesaros, CA; Paulukinas, RD; Penning, TM | 1 |
| Cochran, BJ; Edwards, MC; Gilchrist, RB; Handelsman, DJ; Hu, Y; Ledger, WL; Padmanabhan, V; Rodriguez Paris, V; Rye, KA; Walters, KA; Xiong, T | 1 |
| Divall, S; Feng, M; Fu, X; Jones, D; Ubba, V; Wang, H; Wu, S; Yang, L; Yang, X | 1 |
| Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
| Anesetti, G; Chávez-Genaro, R; Hernández, K; Toledo, A | 1 |
| Brown, RSE; Campbell, RE; Desroziers, E; Khant Aung, Z; Masih, RR | 1 |
| Banks, DB; Binder, AK; Gutierrez, SD; Korach, KS; Magaña, J; Peecher, DL; Qvigstad, AJ | 1 |
| Guo, Z; Liu, D; Lv, L; Ma, H; Radovic, C | 1 |
| Baker, M; Dancz, CE; Legro, RS; Ma, L; Mandelbaum, R; Sriprasert, I; Stanczyk, FZ | 1 |
| Djordjevic, A; Ignjatović, Đ; Macut, D; Mićić, B; Tomić, M; Tovilović-Kovačević, G; Vojnović Milutinović, D | 1 |
| Anderson, GM; Inglis, MA; Kerbus, RI | 1 |
| Jahangiri, S; Librach, CL; Osuga, Y; Salehi, R; Tsang, B; Tzeng, CR; Urata, Y; Wyse, BA | 1 |
| Billig, H; Brännström, M; Hu, M; Huang, X; Li, Y; Lu, Y; Sferruzzi-Perri, AN; Shao, LR; Zhang, X; Zhang, Y | 1 |
| He, JJ; Jing, YX; Li, HX; Li, YM; Yu, X; Yue, F; Zhang, XH | 1 |
| Hsia, SM; Lin, PH; Wang, KL; Wang, PS | 1 |
| Fiocco, A; Isidoro, C; Lima, P; Mazier, HL; Nivet, AL; Reunov, AA; Salehi, R; Tsang, BK; Wang, Q | 1 |
| Gopalakrishnan, V; Krishnan, A; Muthusami, S; Periyasamy, L; Ramachandran, I; Stanley, JA | 1 |
| Li, S; Li, Y; Liang, C; Wen, X; Yu, J; Zheng, Y | 1 |
| Bar-Joseph, H; Ben-Ami, I; Miller, I; Nemerovsky, L; Shalgi, R | 1 |
| Aflatounian, A; Cox, MJ; Edwards, MC; Gilchrist, RB; Handelsman, DJ; Ledger, WL; Padmanabhan, V; Rodriguez Paris, V; Walters, KA | 1 |
| Choi, DH; Kim, HR; Kim, YS; Lee, BS; Lee, MH; Lyu, SW; Song, H; Yoon, JA | 1 |
| Baixeras, E; de Fonseca, FR; Gutierrez-Adan, A; Gutierrez-Arroyo, JL; Laguna-Barraza, R; Navarro, JA; Pericuesta, E; Ramos-Ibeas, P; Sanjuan, C; Vera, K | 1 |
| Fu, P; Gao, Z; Ge, Y; Liu, J; Liu, Z; Ma, X; Wang, L; Yan, X; Yao, R | 1 |
| Chen, Y; Cui, T; Li, T; Liu, R; Yang, Y; Yin, C; Zhang, T | 1 |
| Brkljačić, J; Djordjevic, A; Jelača, S; Macut, D; Teofilović, A; Veličković, N; Vojnović Milutinović, D | 1 |
| Billig, H; Cui, P; Feng, Y; Hu, M; Hu, W; Li, X; Ma, T; Shao, LR; Shi, J; Tong, X; Xu, X; Zhang, F | 1 |
| Aflatounian, A; Anderson, RA; Begg, DP; Bertoldo, MJ; Campbell, RE; Edwards, MC; Gilchrist, RB; Handelsman, DJ; Nagarkar, R; Padmanabhan, V; Rodriguez Paris, V; Sucquart, IE; Walters, KA | 1 |
| Davenport, K; Everman, SJ; Logan, MK; Pruett, JE; Romero, DG; Torres Fernandez, ED; Vinson, RM; Yanes Cardozo, LL; Ye, SA | 1 |
| Basnet, J; Huffman, AM; Rezq, S; Romero, DG; Yanes Cardozo, LL | 1 |
| Alamgir, R; Andrisse, S; Bogle, D; Ecelbarger, C; Eregha, N; Lofton, T; McWhorter, P; Myer, J; Seidu, T | 1 |
| Billig, H; Brännström, M; Hu, M; Ma, S; Sferruzzi-Perri, AN; Shao, LR; Wang, X; Wu, X; Yang, F; Zhang, D; Zhang, Y | 1 |
| Kathryn Korkidakis, A; Reid, RL | 1 |
| Benrick, A; Carlström, M; Cushman, SW; Fornes, R; Hu, M; Ivarsson, N; Maciel, GAR; Maliqueo, M; Marcondes, RR; Stener-Victorin, E; Stenkula, KG | 1 |
| Antić, IB; Bursać, B; Djordjevic, A; Macut, D; Macut, JB; Matić, G; Milutinović, DV; Nestorov, J; Nikolić, M; Teofilović, A; Veličković, N; Zidane, AS | 1 |
| Benrick, A; Chanclón, B; Hadi, L; Micallef, P; Shelton, JM; Stener-Victorin, E; Wernstedt Asterholm, I; Wu, Y | 1 |
| Lee, DR; Lim, JJ; Lima, PDA; Salehi, R; Tsang, BK | 1 |
| Cohen-Tannoudji, J; di Clemente, N; El Hachem, H; Fanchin, R; Giton, F; Grynberg, M; Monniaux, D; Pierre, A; Racine, C; Taieb, J; Touleimat, S | 1 |
| Chen, ZJ; Fan, HY; Ji, SY; Li, BT; Liu, HB; Liu, J; Liu, XM; Zhang, YC; Zhang, YL | 1 |
| Gao, J; Jia, L; Li, X; Liu, M; Ma, S; Sun, J; Tsang, SY; Wang, M; Xu, Y; Zhang, H | 1 |
| Campbell, RE; Prescott, M; Silva, MS | 1 |
| Chen, YA; Cheung, A; Leader, A; Lima, PDA; Nivet, AL; Tsang, BK; Tzeng, CR; Wang, Q | 1 |
| An, X; Chen, Z; Cui, P; Feng, Y; Han, S; Li, B; Ma, T; Shao, LR; Tamadon, A; Wang, Y | 1 |
| Hu, Q; Jin, J; Liu, P; Qian, W; Sheng, L; Tang, C; Wang, X; Yu, D; Zhang, J; Zhong, Y; Zhou, H; Zhou, Y | 1 |
| Ding, G; Huang, H; Li, J; Liu, X; Liu, Y; Pan, J; Sheng, J; Wang, F; Wang, Y; Wu, Y; Xu, J; Zhou, C | 1 |
| Cui, P; Feng, Y; Hu, W; Li, X; Ma, T; Shao, LR; Tong, X; Zhang, F | 1 |
| Gu, HC; Hou, M; Huang, HF; Jiang, ZR; Lin, J; Liu, XM; Sheng, JZ; Wang, HH; Wu, YM; Wu, YT; Yang, Q; Zhou, CL | 1 |
| Moulana, M | 1 |
| Christopoulos, G; Coates, M; Franks, S; Hardy, K; Lavery, S; Lerner, A; Liyanage, M; Owens, LA; Poole, G; Simpson, C; Velupillai, J | 1 |
| Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO | 1 |
| Li, MX; Sun, LF; Xiao, TX; Yang, YL; Zhang, JV | 1 |
| Billig, H; Brännström, M; Cui, P; Guo, X; Han, Y; Hu, M; Jia, W; Lager, S; Li, J; Li, W; Liu, G; Sferruzzi-Perri, AN; Shao, LR; Wu, XK; Xu, H; Zhang, Y; Zhao, W | 1 |
| Irahara, M; Iwasa, T; Kawakita, T; Matsuzaki, T; Mayila, Y; Yanagihara, R | 1 |
| Andersson, D; Benrick, A; Carlström, M; Fornes, R; Manti, M; McCann Haworth, S; Pironti, G; Stener-Victorin, E; Zhengbing, Z | 1 |
| Menaker, M; Murphy, ZC; Sellix, MT | 1 |
| Cui, Y; Dai, X; Liu, J; Wang, J; Yan, X; Zhao, N | 1 |
| Butler, MS; Hickey, TE; Liang, X; Norman, RJ; Ricciardelli, C; Tilley, WD; Yang, X | 1 |
| Danser, AH; de Vries, R; Garrelds, IM; Kramer, P; Labruijere, S; Musterd-Bagghoe, UM; Van Den Brink, AM; van Houten, EL; Villalón, CM; Visser, JA | 1 |
| Benko, R; Benyó, Z; Buday, A; Hamar, P; Horvath, EM; Masszi, G; Nadasy, GL; Novak, A; Revesz, C; Ruisanchez, E; Sara, L; Tarszabo, R; Tokes, AM; Varbiro, S | 1 |
| Check, JH; Cohen, R | 1 |
| Bjekić-Macut, J; Božić-Antić, I; Korićanac, G; Macut, D; Matić, G; Nikolić, M; Romić, S; Tepavčević, S; Vojnović Milutinović, D; Žakula, Z | 1 |
| Alrasheed, H; Damiani, GR; De Pergola, G; De Salvia, MA; Loverro, G; Montagnani, M; Tartagni, M; Tartagni, MV | 1 |
| Chua, AK; Goodarzi, MO; Jiang, H; Liu, NA; Xu, N | 1 |
| Antal, P; Benkő, R; Csibi, N; Monori-Kiss, A; Monos, E; Nádasy, GL; Novak, A; Paragi, P; Sára, L; Szekeres, M; Tarszabo, R; Tőkés, AM; Várbíró, S | 1 |
| Antić, IB; Bursać, B; Djordjevic, A; Macut, D; Macut, JB; Matić, G; Nestorović, N; Nikolić, M; Veličković, N; Vojnović Milutinović, D | 1 |
| Brabant, G; Harger, A; Hofer, D; Keevil, B; Lerchbaum, E; Münzker, J; Obermayer-Pietsch, B; Owen, L; Pieber, T; Trummer, C; Ulbing, M | 1 |
| Erbas, O; Ergenoglu, M; Karadadas, N; Taskiran, D; Yavasoglu, A; Yeniel, O; Yildirim, AG; Yildirim, N | 1 |
| Bui, E; do Carmo, JM; Granger, JP; Hall, JE; Lima, R; Maranon, R; Moulana, M; Reckelhoff, JF; Smith, AD; Spradley, FT; Thomas, RL; Zhang, H | 1 |
| Bjekić-Macut, J; Božić-Antić, I; Korićanac, G; Macut, D; Matić, G; Milutinović, DV; Nikolić, M; Rodaljević, S; Stanišić, J; Tepavčević, S | 1 |
| Bi, J; Hoang, V; Mohankumar, SM; Vyas, AK | 1 |
| Grayson, BE; Ressler, IB; Seeley, RJ; Ulrich-Lai, YM | 1 |
| Casson, P; Hurliman, A; Keller Brown, J; Maille, N; Mandala, M; Osol, G | 1 |
| Billig, H; Cui, P; Feng, Y; Guo, YR; Hu, M; Jiang, HY; Li, X; Pishdari, B; Shao, R; Yang, HP | 1 |
| Chen, L; Huang, C; Ma, BH; Pan, YF; Ren, PG; Tang, M; Tsang, BK; Wang, BB; Wang, YF; Xiao, TX; Zabel, BA; Zhang, JV; Zhao, HY | 1 |
| Flück, CE; Galván, JA; Marti, N; Müller, M; Pandey, AV; Perren, A; Tapia, C; Trippel, M | 1 |
| Goto, M; Iwase, A; Kikkawa, F; Kondo, M; Kotani, T; Nakahara, T; Nakamura, T; Osuka, S; Saito, A; Takikawa, S | 1 |
| Ambroziak, U; Bartoszewicz, Z; Bednarczuk, T; Dadlez, M; Jaźwiec, R; Kępczyńska-Nyk, A; Kondracka, A; Kuryłowicz, A; Samborowska, E; Wysłouch-Cieszyńska, A | 1 |
| Azziz, R; Magoffin, D; Nguyen, M; Pall, M | 1 |
| Andres, J; Bobbert, T; Diederich, S; Hartmann, MF; Mai, K; Maser-Gluth, C; Möhlig, M; Pfeiffer, AF; Reinecke, F; Schulte, HM; Spranger, J; Weickert, MO; Wudy, SA | 1 |
| Cajander, S; Lönn, M; Mannerås, L; Stener-Victorin, E | 1 |
| Cabri, P; De Sutter, P; Deforce, D; Dhont, M; Stoop, D; Van Nieuwerburgh, F | 1 |
| Billig, H; Feng, Y; Fernandez-Rodriguez, J; Johansson, J; Mannerås, L; Shao, R; Stener-Victorin, E | 1 |
| Abbott, DH; Herkimer, C; Padmanabhan, V; Recabarren, SE; Veiga-Lopez, A | 1 |
| Li, ZL; Lin, H; Liu, YM; Wang, SH; Wu, CY; Wu, XY; Xiao, WF | 1 |
| Ortega, HH; Padmanabhan, V; Rey, F; Velazquez, MM | 1 |
| Ding, GL; Dong, MY; Huang, HF; Lu, XE; Lv, PP; Qu, F; Sheng, JZ; Shi, BW; Wang, FF; Zhang, D | 1 |
| Keller, SR; Moenter, SM; Nunemaker, CS; Roland, AV | 1 |
| Davis, DD; Lima, R; Lockhart, R; Moulana, M; Racusen, LC; Reckelhoff, JF; Romero, DG; Yanes, LL; Zhang, H | 1 |
| Seeley, RJ; Wilson-Pérez, HE | 1 |
| Billig, H; Egecioglu, E; Feng, Y; Johansson, J; Shao, R; Stener-Victorin, E; Sun, S; Wang, T; Wang, W; Weijdegård, B | 1 |
| Casson, P; Keller, J; Mandala, M; Osol, G | 1 |
| Antal, P; Buday, A; Hamar, P; Horvath, EM; Masszi, G; Monos, E; Nadasy, GL; Sara, L; Varbiro, S | 1 |
| Karels, B; Kramer, P; McLuskey, A; Themmen, AP; van Houten, EL; Visser, JA | 1 |
| Billig, H; Feng, Y; Johansson, J; Mannerås-Holm, L; Shao, R; Stener-Victorin, E | 1 |
| Ding, GL; El-Prince, M; Gao, Q; Huang, HF; Huang, YT; Jin, M; Leung, PC; Pan, HH; Qu, F; Sheng, JZ; Shi, BW; Wang, FF; Yin, R | 1 |
| Li, S; Liu, W; Mao, X; Tao, T; Wang, L; Zhang, P; Zhao, A | 1 |
| Antal, P; Masszi, G; Monori-Kiss, A; Monos, E; Nadasy, GL; Sara, L; Szekeres, M; Varbiro, S | 1 |
| Brown, RE; Caraty, A; Imran, SA; Wilkinson, DA; Wilkinson, M | 1 |
| Kim, JY; Leader, A; Liu, JY; Tsang, BK; Wang, Q; Xue, K | 1 |
| Benko, R; Benyó, Z; Buday, A; Hamar, P; Horvath, EM; Masszi, G; Nadasy, GL; Novak, A; Revesz, C; Sara, L; Tarszabo, R; Varbiro, S | 1 |
| Billig, H; Johansson, J; Lönn, M; Mannerås-Holm, L; Olsson, A; Shao, R; Stener-Victorin, E | 1 |
| Baracat, EC; de Lima, GR; Haidar, MA; Lakryc, EM; Motta, EL; Soares, JM | 1 |
| Allolio, B; Arlt, W; Fassnacht, M; Schlenz, N; Schneider, SB; Wudy, SA | 1 |
| Tomboc, M; Witchel, SF | 1 |
| Dunaif, A; Gnatuk, CL; Kunselman, AR; Legro, RS | 1 |
| Marouliss, GB; Triantafillidis, IK | 1 |
| Cajander, S; Holmäng, A; Lönn, M; Lystig, T; Mannerås, L; Seleskovic, Z; Stener-Victorin, E | 1 |
| Al-Hendy, A; Fadl, AA; Jamaluddin, M; Nagamani, M; Salama, SA; Salih, SM | 1 |
| Holmäng, A; Jonsdottir, IH; Lönn, M; Mannerås, L; Stener-Victorin, E | 1 |
| Baxendale, PM; Jacobs, HS; James, VH | 1 |
| Lobo, RA; Shoupe, D | 1 |
| Kuttenn, F; Mauvais-Jarvis, P; Mowszowicz, I | 1 |
| Hammond, GL; Kuhn, RW; Murai, JT; Nisker, JA; Raymoure, WJ; Siiteri, PK | 1 |
| Hiroi, M; Kawagoe, S | 1 |
| Cunliffe, WJ; Early, AS; Katz, M; Keczkes, K; McGarrigle, HH; Reese, RA; Walton, S | 1 |
| Chang, L; Duffy, DM; Legro, RS; Lobo, RA; Stanczyk, FZ | 1 |
| Gerris, J; Joostens, M; Mahler, C; Van der Meer, S; Van Royen, E; Verhelst, J | 1 |
| Gjønnaess, H | 1 |
| Jakimiuk, AJ; Magoffin, DA; Weitsman, SR | 1 |
| Demisch, K; Magnet, W; Neubauer, M; Schöffling, K | 1 |
| Mahesh, VB; Mattar, E; Toledo, SP | 1 |
| Besch, PK; Buttram, VC; Dill, B; Smith, RG | 1 |
| Kuttenn, F; Lecomte, P; Mandelbaum, J; Mauvais-Jarvis, P; Mowszowicz, I | 1 |
| Bidlingmaier, F; Hammerstein, J; Moltz, L; Römmler, A; Schwartz, U | 1 |
| Burger, CW; Gooren, LJ; Hompes, PG; Spijkstra, JJ; Spinder, T; van den Tweel, JG; van Kessel, H | 1 |
| Lobo, RA | 1 |
| Molta, L; Schwartz, U | 1 |
| Aliffi, A; Calogero, A; Coniglione, F; D'Agata, R; Macchi, M; Maugeri, G; Mongioi, A; Sipione, C; Vicari, E | 1 |
| Dunaif, A | 1 |
| Lobo, RA; Serafini, P | 1 |
| Franks, S; James, VH; Reed, MJ; Scanlon, MJ; Whorwood, CB | 1 |
| Kelver, ME; Nagamani, M; Van Dinh, T | 1 |
| Aakvaag, A; Gjønnaess, H | 1 |
| Hirakawa, S; Ito, A; Mori, Y; Sato, W | 1 |
| Hallberg, MC; Wieland, RG; Zorn, EM | 1 |
| Rosenfield, RL | 1 |
| Horton, R; Ito, T | 1 |
8 review(s) available for dihydrotestosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
A meta-analysis: Effect of androgens on reproduction in sows.
Topics: Androgens; Animals; Dihydrotestosterone; Female; Humans; Male; Ovulation; Polycystic Ovary Syndrome; Swine | 2023 |
Testosterone in Women: Measurement and Therapeutic Use.
Topics: Androgens; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Replacement Therapy; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Sexual Dysfunctions, Psychological; Testosterone | 2017 |
Polycystic ovarian disease: the adrenal connection.
Topics: Adrenal Glands; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Female; Glucocorticoids; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2006 |
Hirsutism.
Topics: 17-Ketosteroids; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Cells, Cultured; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Female; Fibroblasts; Hirsutism; Humans; Liver; Male; Metabolic Clearance Rate; Ovarian Neoplasms; Polycystic Ovary Syndrome; Sebaceous Glands; Sex Hormone-Binding Globulin; Skin; Testosterone | 1981 |
The serum transport of steroid hormones.
Topics: Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Hormones; Humans; Hydrocortisone; Kinetics; Male; Menstruation; Obesity; Ovarian Neoplasms; Polycystic Ovary Syndrome; Reference Values; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1982 |
Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Ovary; Polycystic Ovary Syndrome; Testosterone | 1985 |
Gonadal and adrenal androgen secretion in hirsute females.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Androgens; Androstenedione; Catheterization; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Hirsutism; Humans; Ovarian Neoplasms; Ovary; Polycystic Ovary Syndrome; Testosterone | 1986 |
Relationship of androgens to female hirsutism and infertility.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Androstenedione; Androstenols; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Hydroxysteroids; Infertility, Female; Ovary; Ovulation; Polycystic Ovary Syndrome; Protein Binding; Secretory Rate; Testosterone | 1973 |
6 trial(s) available for dihydrotestosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult | 2019 |
Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androstenediol; Dihydrotestosterone; Female; Finasteride; Glucuronides; Hirsutism; Humans; Patient Satisfaction; Pilot Projects; Polycystic Ovary Syndrome; Severity of Illness Index; Young Adult | 2014 |
Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial.
Topics: Adult; Androgens; Androstenedione; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Fatty Acids, Nonesterified; Female; Heparin; Humans; Infusions, Intravenous; Lipids; Polycystic Ovary Syndrome; Sodium Chloride; Testosterone; Time Factors; Triglycerides | 2008 |
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; 5-alpha Reductase Inhibitors; Adult; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Placebos; Polycystic Ovary Syndrome; Prolactin; Testosterone; Ultrasonography | 2003 |
Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Cholestenone 5 alpha-Reductase; Cross-Over Studies; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Female; Glucocorticoids; Hormones; Humans; Oxidoreductases; Polycystic Ovary Syndrome | 2003 |
Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Dihydrotestosterone; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Luteinizing Hormone; Menstrual Cycle; Polycystic Ovary Syndrome; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2005 |
125 other study(ies) available for dihydrotestosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Dihydrotestosterone; Disease Models, Animal; Female; Ferroptosis; Glutathione; Insulin Resistance; Iron; Male; Malondialdehyde; Mitochondria; Oxidative Phosphorylation; Phospholipid Hydroperoxide Glutathione Peroxidase; Placenta; Polycystic Ovary Syndrome; Pregnancy; Rats, Sprague-Dawley; Signal Transduction; Uterus | 2021 |
Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Body Weight; Diabetes Mellitus, Type 2; Dihydrotestosterone; Electroacupuncture; Female; Gastrointestinal Microbiome; Polycystic Ovary Syndrome; Rats | 2022 |
Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Topics: Androgens; Animals; Dihydrotestosterone; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Luteinizing Hormone; Male; Mice; Neurons; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects | 2022 |
Conversion of Classical and 11-Oxygenated Androgens by Insulin-Induced AKR1C3 in a Model of Human PCOS Adipocytes.
Topics: Adipocytes; Aldo-Keto Reductase Family 1 Member C3; Androgens; Androstenes; Dihydrotestosterone; Female; Humans; Insulin; Polycystic Ovary Syndrome; Testosterone | 2022 |
Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Topics: Adipose Tissue; Adipose Tissue, Brown; Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Female; Hyperandrogenism; Mice; Muscle, Skeletal; Phenotype; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.
Topics: Animals; Dihydrotestosterone; Female; Glucose; Humans; Hyperandrogenism; Liver; Mice; Obesity; Polycystic Ovary Syndrome; Receptors, Androgen; Reproduction | 2022 |
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Structural and functional changes in rat uterus induced by neonatal androgenization.
Topics: Androgens; Animals; Dihydrotestosterone; Female; Humans; Polycystic Ovary Syndrome; Rats; Testosterone; Uterus; Virilism | 2022 |
Enhanced pup retrieval behaviour in a mouse model of polycystic ovary syndrome.
Topics: Androgens; Animals; Dihydrotestosterone; Estrogen Receptor alpha; Female; Maternal Behavior; Mice; Polycystic Ovary Syndrome; Pregnancy; Reproduction; Virilism | 2022 |
Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 1; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred NOD; Polycystic Ovary Syndrome | 2023 |
Quantitation of 5α-androstanedione in normal women and women with PCOS.
Topics: Androgens; Androstenedione; Dihydrotestosterone; Female; Humans; Male; Polycystic Ovary Syndrome; Testosterone | 2023 |
Effects of early life overnutrition and hyperandrogenism on spatial learning and memory in a rat model of polycystic ovary syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Rats; Spatial Learning | 2023 |
Neuronal Ptpn1 and Socs3 deletion improves metabolism but not anovulation in a mouse polycystic ovary syndrome model.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Insulin; Mice; Mice, Knockout; Neurons; Obesity; Polycystic Ovary Syndrome; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2023 |
Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects.
Topics: Animals; Apoptosis; Dihydrotestosterone; Female; Granulosa Cells; Humans; Ki-67 Antigen; Neuropeptide Y; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2023 |
Defective Uterine Spiral Artery Remodeling and Placental Senescence in a Pregnant Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Arteries; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin; Placenta; Polycystic Ovary Syndrome; Pregnancy; Rats; Uterine Artery; Uterus | 2023 |
N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Androgens; Animals; Dihydrotestosterone; Female; Granulosa Cells; Humans; Hyperandrogenism; Ligases; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Proto-Oncogene Proteins c-akt; Rats | 2023 |
Disturbed Gastrointestinal Contractility in a Polycystic Ovary Syndrome Rat Model.
Topics: Acetylcholine; Animals; Calcium Signaling; Carbachol; Colon; Dihydrotestosterone; Disease Models, Animal; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Stomach | 2020 |
Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome.
Topics: Androgens; Animals; Apoptosis; Autophagy; Dihydrotestosterone; Disease Models, Animal; Dynamins; Female; Gonadotropins; Granulosa Cells; Mitochondria; Mitochondrial Dynamics; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley | 2020 |
Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Topics: Animals; Cytokines; Dihydrotestosterone; Disease Models, Animal; Female; Follicle Stimulating Hormone; Hyperandrogenism; Inflammation Mediators; Insulin; Liver; Luteinizing Hormone; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Urocortins | 2020 |
Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
Topics: Animals; Diet, High-Fat; Dihydrotestosterone; Female; Gastrointestinal Microbiome; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley | 2021 |
Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dihydrotestosterone; Disease Models, Animal; Eye Proteins; Female; Granulosa Cells; Humans; Hyperandrogenism; Mice; Nerve Growth Factors; Ovary; Polycystic Ovary Syndrome; Serpins; Signal Transduction | 2020 |
Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Topics: Adipose Tissue; Animals; Brain; Dihydrotestosterone; Disease Models, Animal; Female; Male; Mice, Knockout; Polycystic Ovary Syndrome; Receptors, Androgen | 2020 |
Hyperandrogenic Milieu Dysregulates the Expression of Insulin Signaling Factors and Glucose Transporters in the Endometrium of Patients With Polycystic Ovary Syndrome.
Topics: Androgens; Antigens, CD; Cells, Cultured; Dihydrotestosterone; Endometrium; Female; Glucose Transport Proteins, Facilitative; Humans; Insulin; Polycystic Ovary Syndrome; Receptor, Insulin; Signal Transduction | 2020 |
D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
Topics: Aging; Animals; Blastocyst; Cumulus Cells; Dihydrotestosterone; Disease Models, Animal; Female; Gene Expression Regulation; Glucose Intolerance; Infertility, Female; Inositol; Liver; Male; Mice, Inbred Strains; Oocytes; Phosphorylation; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Testosterone Propionate | 2020 |
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats.
Topics: Animals; Body Weight; Dihydrotestosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gene Expression Regulation; Gene Regulatory Networks; Gonadotropin-Releasing Hormone; Gonadotropins; Hydroxyethylrutoside; Polycystic Ovary Syndrome; Rats; Testosterone | 2020 |
Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome.
Topics: Adult; AMP-Activated Protein Kinases; Androgens; Animals; Aromatase Inhibitors; Dihydrotestosterone; Female; Hep G2 Cells; Hepatocytes; Humans; Letrozole; Liver; Non-alcoholic Fatty Liver Disease; Ovary; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Testosterone; Young Adult | 2020 |
Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Glucocorticoids; Humans; Lipid Metabolism; Liver; Polycystic Ovary Syndrome; Rats; Rats, Wistar | 2021 |
Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats.
Topics: Androgens; Animals; Apoptosis; Autophagy-Related Protein 12; bcl-2 Homologous Antagonist-Killer Protein; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Insulin Resistance; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Obesity; Polycystic Ovary Syndrome; Reactive Oxygen Species; Risk Factors | 2021 |
Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
Topics: Androgens; Animals; Blood Glucose; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Hyperandrogenism; Lectins; Membrane Proteins; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; Receptors, Neurokinin-3; Triglycerides | 2021 |
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Benzhydryl Compounds; Dihydrotestosterone; Disease Models, Animal; Female; Glucosides; Heart; Hyperandrogenism; Polycystic Ovary Syndrome; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cathepsin L; COVID-19; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Kidney; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; SARS-CoV-2; Serine Endopeptidases; Up-Regulation; Virus Internalization | 2021 |
DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice.
Topics: Animals; Body Composition; Body Weight; Dihydrotestosterone; Female; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Liver; Membrane Proteins; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Polycystic Ovary Syndrome; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic | 2021 |
Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Topics: Androgens; Animals; Decidua; Dihydrotestosterone; Embryo Implantation; Endometrium; Female; Hyperandrogenism; Insulin; Insulin Resistance; Male; Mitochondria; Polycystic Ovary Syndrome; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Uterus | 2021 |
Exercise differentially affects metabolic functions and white adipose tissue in female letrozole- and dihydrotestosterone-induced mouse models of polycystic ovary syndrome.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Animals; Body Composition; Body Weight; Cell Size; Dihydrotestosterone; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Glucose Tolerance Test; Insulin Resistance; Letrozole; Lipid Metabolism; Liver; Mice, Inbred C57BL; Nitriles; Organ Size; Phenotype; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Signal Transduction; Triazoles; Triglycerides | 2017 |
Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Inflammation; Insulin; Interleukin-1beta; Interleukin-6; Intra-Abdominal Fat; Obesity, Abdominal; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Signal Transduction | 2017 |
Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
Topics: Adiponectin; Adipose Tissue; Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Insulin Resistance; Mice; Mice, Knockout; Polycystic Ovary Syndrome | 2017 |
Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.
Topics: Animals; Biomarkers; Dihydrotestosterone; Disease Models, Animal; Female; Gonadotropins; Humans; Ovarian Follicle; Polycystic Ovary Syndrome; Rats; Receptors, Androgen; Signal Transduction; Stem Cell Factor; Ubiquitination | 2017 |
Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.
Topics: Adult; Anti-Mullerian Hormone; Case-Control Studies; Dihydrotestosterone; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Follicular Phase; Gene Expression Regulation; Granulosa Cells; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Receptors, Peptide; Receptors, Transforming Growth Factor beta; Young Adult | 2017 |
The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Proteins; Cell Proliferation; Chorionic Gonadotropin; Dihydrotestosterone; Disease Models, Animal; Female; Gene Expression Regulation; Gonadotropins, Equine; Granulosa Cells; Horses; Humans; Hyperandrogenism; Luteinizing Hormone; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovary; Ovulation; Phosphoproteins; Polycystic Ovary Syndrome; Primary Cell Culture; Signal Transduction; YAP-Signaling Proteins | 2017 |
MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model.
Topics: Androgens; Animals; Apoptosis; Aromatase; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Dihydrotestosterone; Disease Models, Animal; Estradiol; Female; Granulosa Cells; Mice; MicroRNAs; Polycystic Ovary Syndrome; Testosterone | 2017 |
Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.
Topics: Androgen Receptor Antagonists; Androgens; Animals; Brain; Dihydrotestosterone; Feedback, Physiological; Female; GABAergic Neurons; Gonadotropin-Releasing Hormone; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuronal Plasticity; Ovary; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Androgen; Virilism | 2018 |
Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
Topics: Androgens; Animals; Apoptosis; Cell Movement; Chemokines; Dihydrotestosterone; Disease Models, Animal; Female; Granulosa Cells; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Macrophages; Monocytes; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Receptors, Chemokine | 2018 |
Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
Topics: Acupuncture Therapy; Animals; Body Weight; CpG Islands; Dihydrotestosterone; DNA Methylation; Electroacupuncture; Female; Hypothalamus; Insulin Resistance; Polycystic Ovary Syndrome; Rats; Rats, Wistar | 2018 |
Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Carotenoids; Crocus; Dihydrotestosterone; Disease Models, Animal; Drugs, Chinese Herbal; Estrous Cycle; Female; Hypothalamo-Hypophyseal System; Hypothalamus, Anterior; Kisspeptins; Neurons; Ovary; Polycystic Ovary Syndrome; Vitamin A | 2018 |
Mechanism underlying the retarded nuclear translocation of androgen receptor splice variants.
Topics: Active Transport, Cell Nucleus; alpha Karyopherins; Alternative Splicing; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Dihydrotestosterone; Female; Gene Expression; HEK293 Cells; HSP90 Heat-Shock Proteins; Humans; Polycystic Ovary Syndrome; Protein Binding; Receptors, Androgen | 2019 |
Endogenous Ovarian Angiogenesis in Polycystic Ovary Syndrome-Like Rats Induced by Low-Frequency Electro-Acupuncture: The CLARITY Three-Dimensional Approach.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Electroacupuncture; Female; Imaging, Three-Dimensional; Neovascularization, Physiologic; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Rats, Wistar | 2018 |
Prenatal exposure to testosterone induces cardiac hypertrophy in adult female rats through enhanced Pkcδ expression in cardiac myocytes.
Topics: Acetophenones; Androgens; Animals; Animals, Newborn; Benzopyrans; Cardiomegaly; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Myocytes, Cardiac; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Protein Kinase C-delta; Rats; Receptors, Androgen; Signal Transduction; Testosterone; Tetradecanoylphorbol Acetate | 2019 |
Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Hyperandrogenism; Immunophenotyping; Leukocytes; Phenotype; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Expression of genes controlling steroid metabolism and action in granulosa-lutein cells of women with polycystic ovaries.
Topics: Adult; Androgens; Body Mass Index; Cells, Cultured; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Gene Expression Regulation; Gene Regulatory Networks; Granulosa Cells; Humans; In Vitro Oocyte Maturation Techniques; Luteal Cells; Models, Biological; Ovulation; Polycystic Ovary Syndrome; Receptors, Estrogen; Reference Standards; Steroids | 2019 |
Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Topics: Adipose Tissue; Animals; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Female; Gene Expression; Hyperandrogenism; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Ovary; Polycystic Ovary Syndrome; Stimulation, Chemical; Time Factors | 2019 |
Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Animals; Dihydrotestosterone; Female; Glycogen; Hyperandrogenism; Insulin Resistance; Kelch-Like ECH-Associated Protein 1; Mitochondria; NF-E2-Related Factor 2; Polycystic Ovary Syndrome; Pregnancy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase-1; Trophoblasts | 2019 |
The effects of chronic oxytocin administration on body weight and food intake in DHT-induced PCOS model rats.
Topics: Adipocytes; Alanine Transaminase; Androgens; Animals; Aspartate Aminotransferases; Body Weight; Cell Size; Dihydrotestosterone; Disease Models, Animal; Eating; Female; Intra-Abdominal Fat; L-Lactate Dehydrogenase; Ovarian Cysts; Ovary; Oxytocics; Oxytocin; Polycystic Ovary Syndrome; Rats | 2020 |
Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring.
Topics: Animals; Diet, High-Fat; Dietary Sucrose; Dihydrotestosterone; Disease Models, Animal; Energy Metabolism; Female; Gene Expression Regulation; Hypertrophy, Left Ventricular; Maternal Exposure; Mesenteric Arteries; Mice, Inbred C57BL; Myocardium; NADPH Oxidases; Obesity; Polycystic Ovary Syndrome; Pregnancy; Sex Factors; Sexual Development; Sodium-Calcium Exchanger; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Excess androgen during puberty disrupts circadian organization in female rats.
Topics: Adipose Tissue; Androgens; Animals; Body Weight; Circadian Clocks; Cornea; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Liver; Motor Activity; Ovarian Follicle; Period Circadian Proteins; Polycystic Ovary Syndrome; Rats; Rats, Transgenic; Sexual Maturation | 2013 |
Prenatal androgen excess programs metabolic derangements in pubertal female rats.
Topics: Androgens; Animals; Dihydrotestosterone; Female; Fetal Development; Follicular Atresia; Glucose Intolerance; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Muscle, Skeletal; Ovarian Cysts; Ovarian Follicle; Phosphorylation; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |
Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.
Topics: Adult; Carrier Proteins; Case-Control Studies; Cell Line, Tumor; China; Dihydrotestosterone; Female; Granulosa Cell Tumor; Humans; Middle Aged; Molecular Chaperones; Ovary; Polycystic Ovary Syndrome; Protein Transport; Receptors, Androgen; RNA Interference; RNA, Messenger; South Australia; Transfection | 2013 |
Analysis of the vascular responses in a murine model of polycystic ovary syndrome.
Topics: Acetylcholine; Animals; Aorta; Dihydrotestosterone; Disease Models, Animal; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; Vasodilation | 2013 |
Effects of vitamin D3 derivative--calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Calcitriol; Dihydrotestosterone; Disease Models, Animal; Female; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 2013 |
Dihydrotestosterone may contribute to the development of migraine headaches.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; Finasteride; Humans; Migraine Disorders; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2013 |
Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome.
Topics: Animals; Biological Transport; Dihydrotestosterone; Extracellular Signal-Regulated MAP Kinases; Female; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin Resistance; Myocardium; Phosphorylation; Polycystic Ovary Syndrome; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction | 2014 |
Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes.
Topics: Androgens; Animals; Blood Glucose; Dihydrotestosterone; DNA Methylation; Epigenesis, Genetic; Female; Glucose; Homeostasis; Humans; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Testosterone; Zebrafish | 2014 |
Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes.
Topics: Animals; Cholecalciferol; Cyclooxygenase 2; Dihydrotestosterone; Disease Models, Animal; Female; Lower Extremity; Nitric Oxide Synthase Type III; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Saphenous Vein; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Venous Pressure | 2014 |
Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Androgens; Animals; Dihydrotestosterone; Fatty Acid Synthase, Type I; Female; Glucocorticoids; Intra-Abdominal Fat; Nuclear Proteins; Obesity; Phosphoenolpyruvate Carboxykinase (ATP); Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Glucocorticoid; Sterol Regulatory Element Binding Protein 1 | 2015 |
Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Topics: Adolescent; Adult; Biomarkers; Dihydrotestosterone; Female; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Middle Aged; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2015 |
Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Anti-Mullerian Hormone; Antioxidants; Biomarkers; Dihydrotestosterone; Disease Models, Animal; Female; Glutathione Peroxidase; Insulin-Like Growth Factor I; Ovarian Follicle; Ovary; Oxidative Stress; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats.
Topics: Adrenergic Antagonists; Animals; Arterial Pressure; Dihydrotestosterone; Disease Models, Animal; Female; Hormone Antagonists; Hyperandrogenism; Hypertension; Hypothalamus; Kidney; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 4; Signal Transduction; Sympathectomy; Sympathetic Nervous System; Time Factors | 2015 |
Cardiac Nitric Oxide Synthases and Na⁺/K⁺-ATPase in the Rat Model of Polycystic Ovary Syndrome Induced by Dihydrotestosterone.
Topics: Animals; Cell Membrane; Dihydrotestosterone; Disease Models, Animal; Down-Regulation; Female; Myocardium; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Polycystic Ovary Syndrome; Protein Processing, Post-Translational; Protein Transport; Random Allocation; Rats, Wistar; Serine; Sodium-Potassium-Exchanging ATPase; Threonine; Up-Regulation | 2015 |
Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.
Topics: Abdominal Fat; Animals; Blood Pressure; Cholesterol; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Glucose; Hypertension; Liraglutide; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Telemetry; Weight Gain | 2015 |
Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.
Topics: Adiposity; Animals; Behavior, Animal; Body Weight; Diet, High-Fat; Dihydrotestosterone; Disease Models, Animal; Energy Intake; Female; Glucose Intolerance; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Rats; Rats, Long-Evans; Stress, Psychological | 2015 |
Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
Topics: Androgen Antagonists; Androgens; Animals; Arteries; Blood Pressure; Body Weight; Dihydrotestosterone; Endothelium, Vascular; Female; Flutamide; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Random Allocation; Rats, Wistar; Time Factors; Vasodilation | 2015 |
Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome.
Topics: Adenylate Kinase; Animals; Cyclin-Dependent Kinase Inhibitor p21; Dihydrotestosterone; Endometrium; Female; Flutamide; Humans; In Vitro Techniques; Ki-67 Antigen; Phosphorylation; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Androgen | 2015 |
CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.
Topics: Animals; Apoptosis; Dihydrotestosterone; Estrous Cycle; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Gonadal Steroid Hormones; Mice; Mice, Knockout; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Receptors, Chemokine; Receptors, G-Protein-Coupled; Receptors, Steroid; RNA, Messenger; Steroids | 2016 |
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome.
Topics: Adolescent; Adrenal Glands; Adult; Biosynthetic Pathways; Child; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Ovary; Polycystic Ovary Syndrome; Testis; Young Adult | 2017 |
Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Gonadal Steroid Hormones; Gonadotropins; Hypothalamo-Hypophyseal System; Hypothalamus, Anterior; Kisspeptins; Ovary; Phenotype; Polycystic Ovary Syndrome; Rats, Wistar | 2017 |
Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
Topics: Adipose Tissue; Adolescent; Adult; Androstenedione; Body Composition; Body Mass Index; Case-Control Studies; Chromatography, Liquid; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Prognosis; Tandem Mass Spectrometry; Testosterone; Waist Circumference; Young Adult | 2017 |
Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Female; Humans; Insulin; Polycystic Ovary Syndrome; Testosterone | 2009 |
Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS.
Topics: Acupuncture Therapy; Adipose Tissue; Animals; Dihydrotestosterone; Disease Models, Animal; Exercise Therapy; Female; Gene Expression Regulation; Nerve Growth Factor; Neuropeptide Y; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; Receptors, Androgen; RNA, Messenger; Sympathetic Nervous System | 2009 |
Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alleles; Androgens; Androstenedione; Dihydrotestosterone; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Genetic; Receptors, Androgen; Trinucleotide Repeats | 2008 |
Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
Topics: Animals; Dihydrotestosterone; Electroacupuncture; Female; Hypothalamus; Neurosecretory Systems; Polycystic Ovary Syndrome; Rats | 2009 |
Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.
Topics: Animal Feed; Animals; Dihydrotestosterone; Female; Obesity; Overweight; Polycystic Ovary Syndrome; Pregnancy; Pregnancy, Animal; Sheep; Testosterone; Weight Gain | 2010 |
Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.
Topics: Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Hypothalamus; Luteinizing Hormone; Nipples; Ovarian Follicle; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Messenger; Testosterone | 2010 |
Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.
Topics: Adiponectin; Animals; Dihydrotestosterone; Female; Fetus; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Ovary; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Protein Serine-Threonine Kinases; Receptor, Insulin; Sheep; Signal Transduction; Testosterone; TOR Serine-Threonine Kinases | 2010 |
Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway.
Topics: Adult; Analysis of Variance; Aquaporins; Blotting, Western; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Follicular Fluid; Granulosa Cells; Humans; Hyperandrogenism; Luteinizing Hormone; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Reverse Transcriptase Polymerase Chain Reaction; Sex Hormone-Binding Globulin; Signal Transduction; Testosterone | 2010 |
Prenatal androgen exposure programs metabolic dysfunction in female mice.
Topics: Adipocytes; Aging; Androgens; Animals; Body Composition; Calcium; Dihydrotestosterone; Female; Glucose Intolerance; Insulin; Islets of Langerhans; Mice; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects | 2010 |
Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.
Topics: Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Dihydrotestosterone; Disease Models, Animal; Estradiol; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Kidney Diseases; Leptin; Metabolic Syndrome; Oxidative Stress; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2011 |
The effect of vertical sleeve gastrectomy on a rat model of polycystic ovarian syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Gastrectomy; Male; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Weight Loss | 2011 |
Effects of androgen and leptin on behavioral and cellular responses in female rats.
Topics: Androgens; Animals; Behavior, Animal; Body Weight; Brain; Cell Physiological Phenomena; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Leptin; Maze Learning; Organ Size; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Androgen | 2011 |
Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity.
Topics: Acetylcholine; Animals; Dihydrotestosterone; Endothelial Cells; Endothelium, Vascular; Female; Polycystic Ovary Syndrome; Prostaglandins; Rats; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 2011 |
Arteriolar insulin resistance in a rat model of polycystic ovary syndrome.
Topics: Acetylcholine; Animals; Arterioles; Blood Glucose; Cholecalciferol; Dihydrotestosterone; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2012 |
Reproductive and metabolic phenotype of a mouse model of PCOS.
Topics: Adiponectin; Animals; Body Weight; Dihydrotestosterone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Humans; Immunohistochemistry; Insulin; Leptin; Lipid Metabolism; Luteinizing Hormone; Mice; Mice, Inbred C57BL; Ovarian Follicle; Ovary; Phenotype; Polycystic Ovary Syndrome; Reproduction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5α-dihydrotestosterone-induced rat polycystic ovary syndrome model.
Topics: Acupuncture Therapy; Animals; Arcuate Nucleus of Hypothalamus; Dihydrotestosterone; Disease Models, Animal; Electroacupuncture; Estrous Cycle; Female; Polycystic Ovary Syndrome; Progesterone; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu; Testosterone | 2012 |
A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.
Topics: Acetylation; Animals; Anti-Mullerian Hormone; Cells, Cultured; Dihydrotestosterone; DNA Methylation; Female; Granulosa Cells; Histone Deacetylases; Humans; Hyperandrogenism; Nuclear Receptor Co-Repressor 1; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley | 2012 |
The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients.
Topics: Adiponectin; Adipose Tissue; Adult; Dihydrotestosterone; Female; Humans; Leptin; Oxidoreductases; Polycystic Ovary Syndrome; PPAR gamma; RNA, Messenger; Testosterone; Young Adult | 2012 |
Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D₃ treatment.
Topics: Animals; Arterioles; Cardiovascular Agents; Cardiovascular Diseases; Cholecalciferol; Dihydrotestosterone; Disease Models, Animal; Drug Implants; Endothelium, Vascular; Female; Injections, Subcutaneous; Muscle, Skeletal; Muscle, Smooth, Vascular; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Thigh; Vascular Resistance; Vasoconstriction; Vasodilation | 2012 |
Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
Topics: Adipose Tissue; Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Dihydrotestosterone; Energy Metabolism; Female; Gonadal Steroid Hormones; Hypothalamus; Immunohistochemistry; Kisspeptins; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2012 |
Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome.
Topics: Adipokines; Animals; Aromatase; Chemokines; Cholesterol Side-Chain Cleavage Enzyme; Dihydrotestosterone; Disease Models, Animal; Female; Follicle Stimulating Hormone; Gene Expression; Gonadal Steroid Hormones; Granulosa Cells; Intercellular Signaling Peptides and Proteins; Ovarian Follicle; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Steroidogenic Factor 1 | 2012 |
Altered insulin-induced relaxation of aortic rings in a dihydrotestosterone-induced rodent model of polycystic ovary syndrome.
Topics: Animals; Aorta; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Vasodilation; Vitamin D | 2013 |
Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling.
Topics: Acupuncture Therapy; Adipose Tissue; Animals; Dihydrotestosterone; Disease Models, Animal; Electric Stimulation; Female; Glucose; Humans; Insulin; Muscle Contraction; Muscle, Skeletal; Musculoskeletal Manipulations; Polycystic Ovary Syndrome; Rats; Signal Transduction | 2013 |
Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.
Topics: Adolescent; Androstane-3,17-diol; Androstenedione; Child; Dihydrotestosterone; Female; Gene Frequency; Genotype; Glucuronosyltransferase; Heterozygote; Homozygote; Humans; Hyperandrogenism; Phenotype; Polycystic Ovary Syndrome; Puberty, Precocious; Sex Hormone-Binding Globulin; Testosterone | 2003 |
A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Topics: Adipocytes; Androgens; Animals; Aromatase Inhibitors; Body Composition; Body Weight; Dihydrotestosterone; Disease Models, Animal; Estrous Cycle; Female; Letrozole; Magnetic Resonance Imaging; Mesentery; Muscle, Skeletal; Nitriles; Organ Size; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Testosterone; Triazoles | 2007 |
Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.
Topics: 2-Methoxyestradiol; Animals; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Proliferation; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Female; Gene Expression Regulation, Enzymologic; Granulosa Cells; Humans; Models, Biological; Ovarian Follicle; Ovulation; Polycystic Ovary Syndrome; RNA, Messenger; Steroids; Swine; Tretinoin | 2008 |
Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Animals; Animals, Newborn; Dihydrotestosterone; Electroacupuncture; Female; Gene Expression Regulation; Insulin-Like Growth Factor I; Interleukin-6; Ion Channels; Leptin; Mitochondrial Proteins; Physical Conditioning, Animal; Polycystic Ovary Syndrome; Random Allocation; Rats; Reverse Transcriptase Polymerase Chain Reaction; Uncoupling Protein 2 | 2008 |
Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva | 1983 |
The influence of androgens on insulin resistance.
Topics: Adult; Androgens; Androstane-3,17-diol; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome; Spironolactone; Testosterone | 1984 |
[A simplified method for measuring the binding capacity of sex hormone-binding globulin in human serum and its clinical application (author's transl)].
Topics: Adult; Age Factors; Aged; Amenorrhea; Dihydrotestosterone; Female; Hirsutism; Humans; Male; Methods; Middle Aged; Polycystic Ovary Syndrome; Pregnancy; Sex Hormone-Binding Globulin | 1980 |
Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Biomarkers; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 1995 |
Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Female; Hirsutism; Humans; Infusions, Intravenous; Male; Middle Aged; Polycystic Ovary Syndrome; Prospective Studies; Reference Values; Splanchnic Circulation | 1995 |
Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease.
Topics: Adult; Androstenedione; Clomiphene; Dihydrotestosterone; Estradiol; Female; Follicular Phase; Humans; Laser Therapy; Luteal Phase; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1993 |
Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Body Weight; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Electrocoagulation; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Laparoscopy; Longitudinal Studies; Ovulation; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1998 |
5alpha-reductase activity in women with polycystic ovary syndrome.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Dihydrotestosterone; Female; Gene Expression; Granulosa Cells; Humans; Isoenzymes; Polycystic Ovary Syndrome; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Theca Cells | 1999 |
[Androgens in the plasma of women with hirsutism (author's transl)].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Androgens; Androstenediols; Carcinoma; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Leydig Cell Tumor; Middle Aged; Polycystic Ovary Syndrome; Testosterone | 1975 |
Hormone levels following wedge resection in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone; Testosterone | 1978 |
Saliva as a matrix for measuring free androgens: comparison with serum androgens in polycystic ovarian disease.
Topics: Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva; Testosterone | 1979 |
[12 cases of polycystic ovary type 1 (Stein-Leventhal syndrome): complete hormonal study (author's transl)].
Topics: Androstane-3,17-diol; Androstenedione; Clomiphene; Dihydrotestosterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1978 |
Peripheral steroid-gonadotropin interactions and diagnostic significance of double-stimulation tests with luteinizing hormone-releasing hormone in polycystic ovarian disease.
Topics: Adolescent; Adult; Androgens; Anovulation; Diagnosis, Differential; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1979 |
The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
Topics: Androgens; Dihydrotestosterone; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Neoplasms; Ovary; Polycystic Ovary Syndrome; Staining and Labeling; Steroids; Testosterone; Transsexualism | 1989 |
Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.
Topics: Adult; Androstenedione; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone; Time Factors | 1986 |
Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
Topics: Adult; Androgens; Dihydrotestosterone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1986 |
Increased 5 alpha-reductase activity in idiopathic hirsutism.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Genitalia, Female; Hirsutism; Humans; Luteinizing Hormone; Oxidoreductases; Polycystic Ovary Syndrome; Skin; Testosterone | 1985 |
Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.
Topics: Adult; Androstane-3,17-diol; Androstanols; Body Height; Body Weight; Contraceptives, Oral; Dihydrotestosterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Thyroid Diseases | 1988 |
Hyperinsulinemia in hyperthecosis of the ovaries.
Topics: Androstenedione; Dihydrotestosterone; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Ovarian Diseases; Ovary; Polycystic Ovary Syndrome; Syndrome; Testosterone; Theca Cells; Virilism | 1986 |
Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease.
Topics: Androstenedione; Dihydrotestosterone; Electrocoagulation; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Characterization of androgen-binding protein in the human ovarian capsule and its changes by polycystic ovarian disease.
Topics: Adult; Androgen-Binding Protein; Centrifugation, Density Gradient; Chromatography, Affinity; Dihydrotestosterone; Female; Humans; Middle Aged; Neoplasm Proteins; Ovary; Polycystic Ovary Syndrome | 1985 |
Differential studies on the mechanism of serum androgen and androgen-binding abnormalities in hirsutism.
Topics: Androgen Antagonists; Androgens; Beta-Globulins; Dihydrotestosterone; Estrogens, Conjugated (USP); Female; Hirsutism; Humans; Menstruation Disturbances; Obesity; Polycystic Ovary Syndrome; Prednisone; Protein Binding; Radioimmunoassay; Testosterone | 1973 |
Dihydrotestosterone in human peripheral plasma.
Topics: Chromatography, Gel; Dihydrotestosterone; Female; Hirsutism; Humans; Male; Methods; Ovarian Neoplasms; Polycystic Ovary Syndrome; Protein Binding; Testosterone; Tritium | 1970 |